Company24 trialsPhase 44,264 people
Novartis Pharmaceuticals Corporation
Company10 trialsPhase 42,356 people
Company3 trialsPhase 4560 people
Company1 trialPhase 431 people
Company1 trialPhase 3607 people
Company1 trialPhase 377 people
Company1 trialPhase 275 people
Company1 trialPhase 212 people
National Institute on AgingUS$10.4mNational Institute of Diabetes and Digestive and Kidney DiseasesUS$2.9mJapan Society for the Promotion of ScienceJP¥10.8m
National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of California, San FranciscoUS$702.2k2023–2028
National Institute on AgingUniversity of California, San FranciscoUS$1.5m2018–2028
National Health and Medical Research CouncilUniversity of SydneyA$2m2026–2028
Prognostic biomarkers of allograft in pediatric liver transplantation
Japan Society for the Promotion of ScienceJichi Medical UniversityJP¥2.3m2024–2027
Agencia Nacional de Investigación y DesarrolloPontificia Universidad Catolica de ChileCLP 234.2k2024–2028
Immunometabolic impact of machine perfusion strategies in liver transplantation
UKRI | Medical Research CouncilKing's College London£1.2m2023–2026
Canadian Institutes of Health Research (CIHR) Project GrantUniversity of AlbertaCA$956.3k2022–2026
Home-based EXercise and motivAtional programme before and after Liver Transplantation: ExaLT trial
National Institute for Health and Care ResearchUniversity of Birmingham£1.5m2021–2026
National Institute on AgingUniversity of California, San FranciscoUS$201.9k2020–2022
Japan Society for the Promotion of ScienceTohoku UniversityJP¥3.9m2021–2025
A flush combining a metabolic inhibitor with a mitochondrial protectant reduced tissue injury and improved survival after warm storage in rat liver transplants.A flush combining a metabolic inhibitor with a mitochondrial protectant reduced tissue injury and improved survival after warm storage in rat liver transplants.
Mice lacking the receptor FXR showed poorer immune cell recruitment and delayed liver regrowth after surgical removal of most of the organ.Mice lacking the receptor FXR showed poorer immune cell recruitment and delayed liver regrowth after surgical removal of most of the organ.
Initiating moderate-to-vigorous physical activity was associated with an all-cause mortality hazard ratio of 0.89 compared with remaining inactive over a median 7.9-year…Initiating moderate-to-vigorous physical activity was associated with an all-cause mortality hazard ratio of 0.89 compared with remaining inactive over a median 7.9-year follow-up.